Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to investigate the efficacy, safety, tolerability and pharmacokinetics of MT-8554, compared to placebo, in subjects with painful diabetic peripheral neuropathy.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT05123196
Study type Interventional
Source Mitsubishi Tanabe Pharma Corporation
Contact Clinical Trials Information Desk, to prevent miscommunication,
Phone please email:
Email [email protected]
Status Not yet recruiting
Phase Phase 2
Start date November 2021
Completion date June 2023

See also
  Status Clinical Trial Phase
Completed NCT01726413 - A Clinical Trial to Study the Effects GRC 17536 in Patients With Painful Diabetic Peripheral Neuropathy (Painful Extremities Due to Peripheral Nerve Damage in Diabetic Patients). Phase 2
Recruiting NCT04246619 - Efficacy of Pregabalin and Duloxetine in Patients With PDPN: the Effect of Pain on Cognitive Function, Sleep and Quality of Life Phase 4
Recruiting NCT03520608 - Painful Diabetic Peripheral Neuropathy Study of Chinese OutPatiEnt
Completed NCT03172598 - Study to Assess the Efficacy, Safety and Tolerability of MT- 8554 in Subjects With Painful Diabetic Peripheral Neuropathy Phase 2
Terminated NCT01280747 - Examination of Pregabalin Access for Treatment of Indicated Pain Disorders: the ExPAND Study
Recruiting NCT03176472 - Ricolinostat in Patients With Painful Diabetic Peripheral Neuropathy Phase 2
Completed NCT01455415 - Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain Phase 3